Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Unknown 12Completed 8Recruiting 5Terminated 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Head & Neck 5Endocrine 5

Conditions

Breast Neoplasms 1789Neoplasms 1516Carcinoma, Non-Small-Cell Lung 1053Prostatic Neoplasms 965Colorectal Neoplasms 889Lung Neoplasms 809Pancreatic Neoplasms 583Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 540Stomach Neoplasms 523Ovarian Neoplasms 513Neoplasm Metastasis 492Multiple Myeloma 491Recurrence 417Melanoma 390Squamous Cell Carcinoma of Head and Neck 374Uterine Cervical Neoplasms 366Brain Neoplasms 364Head and Neck Neoplasms 355Esophageal Neoplasms 320Precursor Cell Lymphoblastic Leukemia-Lymphoma 313Endometrial Neoplasms 311Lymphoma 309Triple Negative Breast Neoplasms 301Glioblastoma 298Rectal Neoplasms 284Urinary Bladder Neoplasms 268Sarcoma 266Hematologic Neoplasms 266Colonic Neoplasms 257

Interventions

surufatinib 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Differentiated Thyroid Cancer × Clear all
NCT06671184 2026-05-07

Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy

Shanghai 6th People's Hospital

Recruiting
500 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT05852223 2026-04-20

NePenThe

Istituti Clinici Scientifici Maugeri SpA

Phase 2 Recruiting
25 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT05604963 2026-03-05

HoT

University College, London

Phase NA Recruiting
456 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT05599139 2026-02-06

IULID

University Medical Center Groningen

Phase NA Recruiting
25 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT05989425 2023-08-14

Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Fudan University

Phase 2 Recruiting
32 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡